NewDays delivers cognitive treatment for people with Mild Cognitive Impairment (MCI) and dementia by utilizing cutting-edge AI technology. The platform offers evidence-based, conversation-based therapies that require frequent engagement, which typical healthcare systems struggle to support. Their at-home program combines telehealth visits with clinicians and AI-guided cognitive exercises, making proven treatment more accessible. Early outcomes from their first patient cohort indicate a remarkable one-year delay in symptom progression after approximately five months of therapy, showcasing the effectiveness of their innovative approach.

Newdays.Ai

Newdays.Ai